P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer
Dr Alessandro Crocoli speaks to ecancer about a 15-year retrospective study examining difficult central venous catheter removal in children.
He reports that difficult removal was rare, occurring in less than 1% of more than 3,000 procedures, and was particularly associated with prolonged catheter dwell times and chronic disease.
Dr Crocoli explains that almost half of the difficult cases resulted in a retained catheter fragment, with affected patients managed conservatively without subsequent late complications.
He highlights a shift from aggressive attempts at complete extraction towards a more conservative approach, suggesting that leaving retained intravascular fragments in place may be a safe option for selected asymptomatic patients when standard catheter removal fails.
P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer
Ultra-sensitive ctDNA detects residual disease and predicts recurrence early in RCC
Pirtobrutinib significantly improves PFS in treatment-naïve CLL/SLL compared to bendamustine plus rituximab
Longer follow-up shows promising PFS + MRD negativity for mosunetuzumab use in untreated high tumour burden follicular lymphoma
IPSO guidelines on minimally invasive surgery in paediatric solid tumours
Durvalumab combined with FLOT improves survival in resectable gastric and GEJ adenocarcinoma
Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations
Immediate breast surgery versus deferral of surgery in women aged 70+ years with operable breast cancer
Addition of tafasitamab to lenalidomide plus rituximab significantly improves efficacy in R/R follicular lymphoma